HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
10 hedge funds and large institutions have $957K invested in Hepion Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+6
Holders Change %
+150%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$278K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
-$46K |
| 3 |
VF
Virtu Financial
New York
|
-$15.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $325K | +$325K | +61 | New |
|
2
Renaissance Technologies
New York
| $231K | +$231K | +43 | New |
|
|
OAM
3
Oxford Asset Management
Oxford,
United Kingdom
| $92K | +$92K | +17 | New |
|
|
VF
4
Virtu Financial
New York
| $79K | -$15.8K | -3 | -17% |
|
5
Geode Capital Management
Boston,
Massachusetts
| $74K | +$74K | +14 | New |
|
|
PFS
6
Prospera Financial Services
Dallas,
Texas
| $70K | +$70K | +13 | New |
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $37K | +$37K | +7 | New |
|
8
Morgan Stanley
New York
| $19K | +$19K | +4 | New |
|
|
9
UBS Group
Zurich,
Switzerland
| $18K | -$6K | -1 | -25% |
|
|
APA
10
American Portfolios Advisors
Holbrook,
New York
| $10.7K | +$10.7K | +2 | New |
|
|
SFS
11
Sowell Financial Services
North Little Rock,
Arkansas
| $1K | – | – | – |
|
|
SM
12
Sabby Management
Miami Beach,
Florida
| – | -$278K | -115 | Closed |
|
|
ARTA
13
A.R.T. Advisors
New York
| – | -$46K | -19 | Closed |
|